Skip to main content
TipRanks
Go Ultimate75% OFF

Inovio Pharmaceuticals (INO) Ownership - Who Owns Inovio Pharmaceuticals?

6,101 Followers

Inovio Pharmaceuticals (INO) Ownership Overview

  • 0.21% Insiders
  • 7.89% Mutual Funds
  • 6.64% Other Institutional Investors
  • 2.60% ETFs
  • 82.66% Public Companies and Individual Investors

The ownership structure of Inovio Pharmaceuticals (INO) stock is a mix of institutional, retail, and individual investors. Approximately 17.13% of the company’s stock is owned by Institutional Investors, 0.21% is owned by Insiders, and 82.66% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026Graham Capital Management, L.p.$113,832
Sep 30, 2026 $931,852
Sep 30, 2026Ra Capital Management$8,808,868

Top Shareholders

INO top shareholders
Holder# of SharesType% HoldingValue
Fidelity Securities Fund10,529,144Institution5.62%14,740,802
Peter Kolchinsky7,220,384Institution3.85%10,108,538
Vanguard4,512,212Institution2.41%6,317,097
Vanguard Index Funds3,563,417Institution1.90%4,988,784
BlackRock, Inc.763,813Institution0.41%1,069,338
Fidelity Concord Street Trust285,565Institution0.15%399,791
Ishares254,336Institution0.14%356,070
Bridgeway Funds, Inc.173,000Institution0.09%242,200
Thomas E. Claugus126,119Institution0.07%176,567
Goldman Sachs Trust116,762Institution0.06%163,467

Top Mutual Fund Holders

INO top mutual fund holders
Holder# of SharesType% HoldingValue
Fidelity Securities Fund10,529,144Institution5.62%14,740,802
Vanguard Index Funds3,563,417Institution1.90%4,988,784
Fidelity Concord Street Trust285,565Institution0.15%399,791
Bridgeway Funds, Inc.173,000Institution0.09%242,200
Goldman Sachs Trust116,762Institution0.06%163,467
Vanguard Valley Forge Funds45,128Institution0.02%63,179
Vanguard Institutional Index Funds42,017Institution0.02%58,824
Victory Portfolios Iii28,563Institution0.02%39,988
John Hancock Variable Insurance Trust1,613Institution<0.01%2,258
Morgan Stanley Pathway Funds950Institution<0.01%1,330

Top ETF Holders

INO top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total Stock Market ETF, VTI ETF2,587,459Institution1.38%1,558,685
Vanguard Extended Market ETF, VXF ETF1,228,780Institution0.66%740,217
iShares Micro-Cap ETF, IWC ETF254,336Institution0.14%356,070
Invesco NASDAQ Future Gen 200 ETF, QQQS ETF94,431Institution0.05%135,036
GERM0Institution<0.01%5

FAQ

Who Owns Inovio Pharmaceuticals (INO)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 17.13% of the company's stock is held by institutional investors, 0.21% is held by insiders, and 82.66% is held by public companies and individual investors.
What percentage of Inovio Pharmaceuticals (INO) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 17.13% of Inovio Pharmaceuticals (INO) stock is held by institutional investors: 7.89% by mutual funds, 2.60% by ETFs and 6.64% by other institutional investors.
What percentage of Inovio Pharmaceuticals (INO) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 82.66% of Inovio Pharmaceuticals (INO) stock is held by public companies and individual investors.
Who owns the most shares of Inovio Pharmaceuticals (INO)?
Fidelity Securities Fund owns the most shares of Inovio Pharmaceuticals (INO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.